west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "袖式切除术" 3 results
  • 气管良性狭窄袖式切除重建外科治疗

    目的探讨气管良性狭窄的临床特点和外科手术治疗策略。 方法回顾性分析2011年1月至2013年12月同济医院胸外科收治的15例气管良性狭窄患者的临床资料,男11例、女4例,年龄10~57(34.52±2.45)岁;均为气管内插管后发生狭窄,颈段气管良性狭窄13例,气管中段2例。6例患者行气管狭窄切除并端端吻合重建术,9例行气管狭窄切除端端吻合横行气管切开术。 结果本组15例患者均安全度过麻醉期和手术期,全组无手术死亡。术后发生切口感染及气胸各1例,所有患者均顺利出院。随访3~36个月,所有患者日常活动正常,无呼吸困难症状,无再狭窄发生。 结论气管良性狭窄的治疗首选气管袖式切除重建手术治疗,预防性气管切开利于术后呼吸道管理,减少并发症的发生。

    Release date: Export PDF Favorites Scan
  • Two-incision Approach for Video-assisted Thoracoscopic Sleeve Lobectomy for Lung Cancer

    ObjectiveTo discuss the experiences of video-assisted thoracoscopic surgery (VATS) sleeve lobectomy with bronchoplasty for lung cancer, using only two incisions. MethodWe retrospectively analyzed the clinical data of 16 patients of VATS sleeve lobectomy with bronchoplasty in our hospital between January 2013 and January 2014. There were 14 males and 2 females at age of 55 (39-70) years. The clinical effect was analyzed. ResultsThe patients underwent sleeve lobectomy with bronchoplasty were no severe postoperative complications. Median operative time was 183 min. Median bronchial anastomosis time was 39 min. Median blood loss was 170 ml. The result of pathological examination showed 11 patients with squamous cell carcinomas and 5 patients with adenocarcinoma. Median postoperative chest tube drainage duration was 4.5 days. Median hospital stay was 6.9 days. ConclusionVATS sleeve lobectomy with bronchoplasty is a feasible and safe surgical approach, using only two incisions.

    Release date:2016-10-02 04:56 Export PDF Favorites Scan
  • Efficacy of sleeve lobectomy after neoadjuvant chemoimmunotherapy in lung cancer: A retrospective cohort study

    Objective To evaluate the outcomes of sleeve resection following neoadjuvant chemoimmunotherapy for lung cancer. Methods The clinical data of patients diagnosed with lung cancer and undergo sleeve lobectomy surgery at Tianjin Chest Hospital were retrospectively analyzed. Patients were divided into two groups: a neoadjuvant treatment group and a surgery alone group. The clinical data of two groups were compared. Results Finally 22 patients were collected, including 19 males and 3 females with a median age of 63 years. There were 7 patients in the neoadjuvant treatment group, and 15 patients in the surgery alone group. There was no statistical difference in surgical time, intraoperative bleeding, lymph node dissection, postoperative catheterization time, or postoperative drainage volume between the two groups (P>0.05). In the neoadjuvant treatment group, 1 patient had a second thoracotomy exploration for hemostasis due to bronchial artery bleeding, 2 patients had wound infection, 1 patient had immune-associated pneumonia before surgery, and 1 patient had immune-associated pneumonia before postoperative adjuvant therapy. Postoperative pathological results of patients in the neoadjuvant treatment group showed that 1 (1/7, 14.3%) patient had pathological complete response, and 3 (3/7, 42.9%) patients achieved major pathological response. Conclusion Neoadjuvant chemoimmunotherapy can lead to complications, including operation-related complications and immunotherapy-related complications. However, the degree of postoperative pathological remission is also significantly improved. Overall, sleeve resection following neoadjuvant chemoimmunotherapy can be considered as a treatment option for patients with lung cancer.

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content